Mechanism of long non-coding RNA plasmacytoma variant translocation 1 involved in pelvic organ prolapse

doi:10.12307/2023.092

Abstract

Abstract: BACKGROUND: Previous studies have shown that the expression of long non-coding RNA plasmacytoma variant translocation 1 (LncRNA PVT1) was significantly reduced in the uterine cardinal ligament of patients with pelvic organ prolapse through high-throughput sequencing. Transforming growth factor β1 signaling pathway is also one of the related pathways.
OBJECTIVE: To investigate the effect of LncRNA PVT1 on pelvic floor ligament fibroblasts and its possible role in the pathogenesis of pelvic organ prolapse.
METHODS: Tissue samples of the pelvic floor ligament were extracted from rats and fibroblasts were isolated for primary culture. LncRNA PVT1 interference and overexpression vectors were constructed by lentivirus and added into fibroblasts. Morphology, proliferation, migration and apoptosis of fibroblasts were detected by immunofluorescence, MTT, cell scratch assay and flow cytometry test respectively. The mRNA and protein expressions of transforming growth factor-β1, Smad2/3 and c-Myc were detected by RT-PCR and western blot respectively.
RESULTS AND CONCLUSION: Overexpression of LncRNA PVT1 could significantly promote the proliferation of fibroblasts, improve the migration ability of cells, and inhibit the apoptosis of fibroblasts. The results of LncRNA PVT1 interference were opposite. In addition, the mRNA and protein relative expressions of c-Myc, transforming growth factor-β1 and Smad2/3 were significantly increased when LncRNA PVT1 gene was overexpressed, while the expressions of c-Myc and transforming growth factor-β1 were significantly inhibited when LncRNA PVT1 gene was interfered. To conclude, LncRNA PVT1 can affect the morphology and biological function of fibroblasts, which may be related to the transforming growth factor-β1/Smad2/3/c-Myc pathway. This study provides new ideas for the clinical diagnosis and treatment of pelvic organ prolapse.

Key words: long non-coding RNA, plasmacytoma variant translocation 1, pelvic organ prolapse, fibroblast, overexpression, interference

CLC Number:

Hu Xinming, Qiao Yanhua, Wang Xiaofan, Li Linyu, Zhao Bing. Mechanism of long non-coding RNA plasmacytoma variant translocation 1 involved in pelvic organ prolapse[J]. Chinese Journal of Tissue Engineering Research, 2023, 27(5): 669-675.

Figures/Tables 7

References

[1] HUANG L, ZHAO Z, WEN J, et al. Cellular senescence: A pathogenic mechanism of pelvic organ prolapse (Review). Mol Med Rep. 2020; 22(3):2155-2162.
[2] 朱兰, 陈娟. 《盆腔器官脱垂的中国诊治指南(2020年版)》解读[J]. 中华医学信息导报,2020,35(15):17.
[3] YIN Y, HAN Y, SHI C, et al. IGF-1 regulates the growth of fibroblasts and extracellular matrix deposition in pelvic organ prolapse. Open Med (Wars). 2020;15(1):833-840.
[4] DIEDRICH CM, ROOVERS J, SMIT TH, et al. Fully absorbable poly-4-hydroxybutyrate implants exhibit more favorable cell-matrix interactions than polypropylene. Materi Sci Eng C Mater Biol Appl. 2021;120:111702.
[5] QUINN JJ, CHANG HY. Unique features of long non-coding RNA biogenesis and function. Nat Rev Genet. 2016;17(1):47-62.
[6] 张志磊, 赵冰, 刘灵, 等. 盆底器官脱垂疾病mRNA和lncRNA差异表达谱的综合分析[J]. 郑州大学学报(医学版),2020,55(2):236-242.
[7] PALCAU AC, CANU V, DONZELLI S, et al. CircPVT1: a pivotal circular node intersecting Long Non-Coding-PVT1 and c-MYC oncogenic signals. Molecular Cancer. 2022;21(1):33.
[8] HU HH, CHEN DQ, WANG YN, et al. New insights into TGF-beta/Smad signaling in tissue fibrosis. Chem Biol Interact. 2018;292:76-83.
[9] LIU N, FENG J, LU X, et al. Isorhamnetin Inhibits Liver Fibrosis by Reducing Autophagy and Inhibiting Extracellular Matrix Formation via the TGF-beta1/Smad3 and TGF-beta1/p38 MAPK Pathways. Mediators Inflamm. 2019;2019:6175091.
[10] ZHANG Q, CHANG X, WANG H, et al. TGF-beta1 mediated Smad signaling pathway and EMT in hepatic fibrosis induced by Nano NiO in vivo and in vitro. Environ Toxicol. 2020;35(4):419-429.
[11] ZHANG X, FENG W, ZHANG J, et al. Long noncoding RNA PVT1 promotes epithelialmesenchymal transition via the TGFbeta/Smad pathway in pancreatic cancer cells. Oncol Rep. 2018;40(2):1093-1102.
[12] RAJU R, LINDER BJ. Evaluation and Management of Pelvic Organ Prolapse. Mayo Clin Proc. 2021;96(12):3122-3129.
[13] REN S, XIE B, WANG J, et al. Biomechanics of pelvic organ prolapse. Sci China Life Sci. 2015;58(2):218-220.
[14] WEINTRAUB AY, GLINTER H, MARCUS-BRAUN N. Narrative review of the epidemiology, diagnosis and pathophysiology of pelvic organ prolapse. Int Braz J Urol. 2020;46(1):5-14.
[15] EL MH, LOEUILLARD E, LEMOINNE S, et al. Culture Model of Rat Portal Myofibroblasts. Front Physiol. 2016;7:120.
[16] CANALS J, NAVARRO A, VILA C, et al. Human embryonic mesenchymal lung-conditioned medium promotes differentiation to myofibroblast and loss of stemness phenotype in lung adenocarcinoma cell lines. J Exp Clin Cancer Rese. 2022;41(1):37.
[17] WANG D, HU Y. Long Non-coding RNA PVT1 Competitively Binds MicroRNA-424-5p to Regulate CARM1 in Radiosensitivity of Non-Small-Cell Lung Cancer. Mol Ther Nucleic Acids. 2019;16:130-140.
[18] CHEN J, YU Y, LI H, et al. Long non-coding RNA PVT1 promotes tumor progression by regulating the miR-143/HK2 axis in gallbladder cancer. Mol Cancer. 2019;18(1):33.
[19] LI Y, SUN W, PAN H, et al. LncRNA-PVT1 activates lung fibroblasts via miR-497-5p and is facilitated by FOXM1. Ecotoxicol Environ Saf. 2021; 213:112030.
[20] CAO F, LI Z, DING W, et al. LncRNA PVT1 regulates atrial fibrosis via miR-128-3p-SP1-TGF-β1-Smad axis in atrial fibrillation. Mol Med. 2019; 25(1):7.
[21] MARTINOTTI S, RANZATO E. Scratch Wound Healing Assay. Methods Mol Biol. 2020;2109:225-229.
[22] MCKINNON KM. Flow Cytometry: An Overview. Curr Protoc Immunol. 2018;120:1-5.
[23] WANG J, KONG X, HU H, et al. Knockdown of long non-coding RNA PVT1 induces apoptosis of fibroblast-like synoviocytes through modulating miR-543-dependent SCUBE2 in rheumatoid arthritis. J Orthop Surg Res. 2020;15(1):142.
[24] ZHENG J, YU F, DONG P, et al. Long non-coding RNA PVT1 activates hepatic stellate cells through competitively binding microRNA-152. Oncotarget. 2016;7(39):62886-62897.
[25] NEVZOROVA YA, CUBERO FJ, HU W, et al. Enhanced expression of c-myc in hepatocytes promotes initiation and progression of alcoholic liver disease. J Hepatol. 2016;64(3):628-640.
[26] FEGHALI CA, BOULWARE DW, FERRISS JA, et al. Expression of c-myc, c-myb, and c-sis in fibroblasts from affected and unaffected skin of patients with systemic sclerosis. Autoimmunity. 1993;16(3):167-171.
[27] QIN H, TANG Y, MAO Y, et al. C-MYC induces idiopathic pulmonary fibrosis via modulation of miR-9-5p-mediated TBPL1. Cellular Signalling. 2022;93:110274.
[28] ZHOU Z, NI J, LI J, et al. RIG-I aggravates interstitial fibrosis via c-Myc-mediated fibroblast activation in UUO mice. J Mol Med (Berl). 2020; 98(4):527-540.
[29] ZHANG N, SUN Y. LncRNA ROR facilitates myocardial fibrosis in rats with viral myocarditis through regulating C-Myc expression. Eur Rev Med Pharmacol Sci. 2019;23(24):10982-10988.
[30] JIN K, WANG S, ZHANG Y, et al. Long non-coding RNA PVT1 interacts with MYC and its downstream molecules to synergistically promote tumorigenesis. Cell Mol Life Sci. 2019;76(21):4275-4289.
[31] TSENG YY, MORIARITY BS, GONG W, et al. PVT1 dependence in cancer with MYC copy-number increase. Nature. 2014;512(7512):82-86.
[32] GHADIRI A, SHARIFI M, MEHRZAD V, et al. Reduce proliferation of human bone marrow cells from acute myeloblastic leukemia with minimally differentiation by blocking lncRNA PVT1. Clin Transl Oncol. 2020;22(11):2103-2110.
[33] SHIGEYASU K, TODEN S, OZAWA T, et al. The PVT1 lncRNA is a novel epigenetic enhancer of MYC, and a promising risk-stratification biomarker in colorectal cancer. Mol Cancer. 2020;19(1):155.
[34] LIAN N, LI T. Growth factor pathways in hypertrophic scars: Molecular pathogenesis and therapeutic implications. Biomed Pharmacother. 2016;84:42-50.
[35] 石永英, 卢俊江, 陈广原, 等. p15与c-Myc在TGF-β1诱导的大鼠心肌细胞肥大中的表达及与TGF/Smad信号通路的关系[J]. 中国动脉硬化杂志,2018,26(3):245-252.
[36] 刘红艳, 齐创. 萝卜硫素调控TGF-β1/Smad信号通路抑制结肠癌HT-29细胞增殖的机制研究[J]. 蚌埠医学院学报,2020,45(3):311-314.
[37] HU L, LIU J, LI Z, et al. Transforming growth factor-beta1 activates DeltaNp63/c-Myc to promote oral squamous cell carcinoma. Oral Surg Oral Med Oral Pathol Oral Radiol. 2016;122(4):460-482.
[38] 郝淑玲, 王卫平, 李建东, 等. 肾上腺髓质素和转化生长因子β1对肺成纤维细胞增殖及c-myc表达的影响[J]. 中华实用诊断与治疗杂志,2015,29(4):333-335.